Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_assertion description "[Here, we tested whether Polo-like kinase 1 (PLK1) siRNAs complexed with a Her2-ScFv-protamine peptide fusion protein (F5-P) could suppress Her2(+) breast cancer cell lines and primary human cancers in orthotopic breast cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_assertion evidence source_evidence_literature NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_assertion SIO_000772 22517885 NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_assertion wasDerivedFrom befree-20150227 NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_assertion wasGeneratedBy ECO_0000203 NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.
- befree-20150227 importedOn "2015-02-27" NP630870.RAQ17UbGkBQCzk-5Ff3vhxl9lk0tmwOvNG9N7Di2eJ63E130_provenance.